Evidence map›Paper›PMID 29890191›Full record

ReviewFrontiers in neuroendocrinology2018

Homeostatic sensing of dietary protein restriction: A case for FGF21.

Cristal M Hill, Hans-Rudolf Berthoud, Heike Münzberg, Christopher D Morrison

Abstract readReview
In one paragraph

Review in Frontiers in neuroendocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Weight gain during the menopause transition: Evidence for a mechanism dependent on protein leverage.BJOG : an international journal of obstetrics and gynaecology · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cristal M HillPennington Biomedical Research Center, Baton Rouge, LA 70808, United States.
Hans-Rudolf BerthoudPennington Biomedical Research Center, Baton Rouge, LA 70808, United States.
Heike MünzbergPennington Biomedical Research Center, Baton Rouge, LA 70808, United States.
Christopher D MorrisonPennington Biomedical Research Center, Baton Rouge, LA 70808, United States. Electronic address: Christopher.Morrison@pbrc.edu.

Funding

Leptin and Central Control of ThermoregulationR01DK092587 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI MUENZBERG-GRUENING, HEIKE · 2012 to 2024
$3.5M
FGF21 is an endocrine signal of protein restrictionR01DK105032 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI MORRISON, CHRISTOPHER D · 2016 to 2019
$1.4M
Neuronal FGF21 Signaling in the Detection of Dietary Protein RestrictionF32DK115137 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI HILL, CRISTAL MONIQUE · 2017 to 2019
$185k
NIDDK NIH HHS F32 DK115137NIDDK NIH HHS R01 DK092587NIDDK NIH HHS R01 DK105032
6 · The paper itself

Abstract

Restriction of dietary protein intake increases food intake and energy expenditure, reduces growth, and alters amino acid, lipid, and glucose metabolism. While these responses suggest that animals 'sense' variations in amino acid consumption, the basic physiological mechanism mediating the adaptive response to protein restriction has been largely undescribed. In this review we make the case that the liver-derived metabolic hormone FGF21 is the key signal which communicates and coordinates the homeostatic response to dietary protein restriction. Support for this model centers on the evidence that FGF21 is induced by the restriction of dietary protein or amino acid intake and is required for adaptive changes in metabolism and behavior. FGF21 occupies a unique endocrine niche, being induced when energy intake is adequate but protein and carbohydrate are imbalanced. Collectively, the evidence thus suggests that FGF21 is the first known endocrine signal of dietary protein restriction.

Indexed as

Diet, Protein-RestrictedAnimalsDietary CarbohydratesDietary ProteinsFeeding BehaviorFibroblast Growth FactorsHomeostasisDietary CarbohydratesDietary Proteinsfibroblast growth factor 21Fibroblast Growth FactorsDietary proteinFGF21MacronutrientNutrition

Identifiers

PMID29890191
PMCPMC6175661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.